A previous clinical study reported that the serum TXNIP levels were elevated in patients with obesity and diabetes and that bariatric surgery resulted in a significant reduction in serum TXNIP levels as early as 1 month postoperatively [14]. This evidence concerns the gene TXNIP and obesity disorder.